medigraphic.com
ISSN 0016-3813 (Print)

2002, Number 4

<< Back Next >>

Gac Med Mex 2002; 138 (4)

Factors That Modified Medical Practice.
I. Introduction.
II. Resource Administration in Medicine.
III. Physician and Hospital Demands.
IV. The Impact of Technology on the Practice of the Medical Profession.
V. Financial Skemas.
V

Rivero-Serrano O

Language: Spanish
References: 71
Page: 331-346
PDF size: 84.66 Kb.


Text Extraction

No abstract


REFERENCES

  1. Wise J. Se eleva la expectativa de vida a nivel mundial BMJ 1998;6:204.

  2. Terrés SAM. Medicina del tercer milenio. Rev Med IMSS 1998;36(3):245-52.

  3. Savill J. El papel de la biología molecular en la comprensión de las enfermedades. BJM 1997;5:171-174.

  4. Michel BC, Van Hout BA, Bonsel GJ. Assessing the benefits of transplant services. Bailler’s Clin Gastr 1994;8(3):411-23.

  5. Wilson CB. The impact of medical technologies on the future of hospitals. BJM 1999;319:1287-94.

  6. Dowie R, Langman M. Staffing of hospitals: future needs, future provision. BJM 1999;319:1193-95.

  7. Rodwin MA. Conflict in managed care. N Engl J Med 1995;332(9)604-07.

  8. Frankel T. Fiduciary law. Calif Law Rev 1983;71:795-836.

  9. Mariner WK. Business vs. medical ethics: conflicting standards for managed care. J Law Ethics 1995;23:236-46.

  10. Kassierer JP. Managed care and the morality of the marketplace. N Engl J Med 1995;333(1):50-2.

  11. Feldman D, et al. Effects of managed care on physician-patient relationship, quality of care, and the ethical practice of medicine: a physician survey. Arch Intern Med 1998;158(15):1626-32.

  12. Li J. The patient-physician relationship: covenant or contract? Mayo Clin Proc 1996;71(9):917-18

  13. Glass RM. The patient-physician relationship. Focuses on the center of medicine. JAMA 1996;275(2):147-8.

  14. Emanuel EJ, Dubler NN. Preserving the physician-patient relationship in the era of managed care. JAMA 1995;273 (4):323-9.

  15. Crawshaw R, Rogers DE, Pellegrino ED, et al. Patient-physician covenant. JAMA 1995;273:1553.

  16. Iglehart JK. The American health care system-expenditures. N Engl J Med 1999;340(1):70-6.

  17. Robinson JC. HMO market penetration and hospital cost inflammation in California. JAMA 1991;266(19): 2719-23.

  18. Hirschfleld EB. Should third payers of health care services disclose cost control mechanisms to potential beneficiaries? Seton Hall Legis J 1990;13:115.

  19. Woolhanlder S, Ifimmelstein DU. The deteriorating administrative efficiency of the US Health Care System. N Engl J Med 1991;324(18):1253-58.

  20. Woolhandler S, Femmelstein DU. Costs of care and administration at for-profit and other hospitals in the United States. N Engl J Med 1997;336(11):769-74.

  21. Patiño Retrepo JF. Reforma y crisis de la salud. Ley 100 de 1993, Academia Medicina Colombia; 1999.

  22. Stocker K, Waitzkin H, Iriart C. The exploration of managed care to Latin America. N Engl J Med 1999;340(14):1131-6.

  23. Hillman AL. Financial incentives for physicians in HMOS: is there a conflict of interest? N Engl J Med 1987;317:1743-8.

  24. Rodwin MA. Medicine. Money and morals.-physicians conflict of interest New York; Oxford University Press; 1993.

  25. Johnson J, Nfitka M. Managed care maelstrom. Am Med News July 25, 1994:1.

  26. Angell M. The doctor as a double agent. Kennedy Inst Ethics J 1993;3:2279-86.

  27. Laurell AC. Health reform in Mexico: the Promotion of inequality. Int J Health Serv 2001;31(2):291-321.

  28. 1 . Rivero-Serrano O. Los altos costos de la medicina actual. Ponencias y Discursos 1995-2000. México: Consejo de Salubridad General; 2000.

  29. Miller GA. HMOs say: "Doctors and patients are the problem!". In: Speak now or forever rest in peace. Gordon Miller, MD, Publisher; 1997. p. 55-64

  30. Lifshitz A. El racionamiento de la atención médica. Rev Preven Salud 2001;2(6):19-20.

  31. Beauchamp TL, Childress JF. Principles of biomedical ethics. 5th ed. Oxford University Press; 2001.

  32. Berkman S. The HMO survival guide. New York: Villard Books; 1997

  33. Cordera-Pastor A. Administración de salud y ética. Direc Med 2001;8:14-8.

  34. 1. Aris A. Las anécdotas de la medicina. 1st ed. México: Editorial Planeta Mexicana; 1999.

  35. 2. Carrillo Fabela LMR. La responsabilidad profesional del médico. 3rd ed. México: Roma; 2000.

  36. 3. Código civil para el Distrito Federal en materia común y para toda la república en materia federal. México: Editorial Sista; 1998.

  37. 4. Código Penal Federal. Colección penal. 3rd ed. México: Ediciones Delma; 2000.

  38. 5. CONAMED. Cuaderno de divulgación. Preguntas y respuestas sobre CONAMED. México; 1997.

  39. 6. CONAMED. Cuarto informe de actividades México. 2000

  40. 7. Fernández Varela MH. La responsabilidad profesional y jurídica de la práctica médica. Simposio, Academia Mexicana de Cirugía. México, D.F.: 1999.

  41. 8. García Ramírez S. La responsabilidad penal del médico. 1st ed. México: Editorial Porrúa; 2001.

  42. 9. Legislación Sanitaria. Ley General de Salud. 6th ed. México: Ediciones Delma; 2000.

  43. López Muñoz, Gustavo y Larraz. Defensas en las negligencias médicas. Editorial Dykinson; 1991.

  44. Rivero O, Tanimoto M. editores. El ejercicio actual de la medicina. México, D.F.: Ed. Siglo XXI; 2000.

  45. Uribe M, López M. editores. Evaluación de tecnologías en salud 2000. México, D.F.: Ed. Médica Sur; 2000.

  46. Rao PM, et al. Effect of computed tomography of the appendix on treatment of patients and use of hospital resources. N Engl J Med 1998;336:141-146.

  47. Seder RA, Gurunathan S. DNA vaccines designer vaccines for the 21st century. N Engl J Med 1999;341:277-283.

  48. Shekelle PA, et al. The reproducibility of a method to identify the overuse and underuse of medical procedures. N Engl J Med 1998;338:1888-1895.

  49. Martin JB, Kasper DL. In whose best interest? Breaching the academic industrial wall. N Engl J Med 2000;343: 1646-1649.

  50. Lo B, Wolf LE, Berkeley A. Conflict-of-interest. Policies for investigators in clinical trials. N Engl J Med 2000;343: 1616-1620.

  51. Ferguson JR. Biomedical research and insider trading. N Engl J Med 1997;337:631-634.

  52. Inglehart JK. Physicians as agents of social control: the thoughts of Victor Fuchs. Health Aff (Millwood) 1998;17 (1):90-6.

  53. San Martín H, Pastor V. Economía de la salud.Madrid, España: Interamericana, McGraw-Hill; 1989:583-586.

  54. San Martín H, Pastor V. Ibid., p.45.

  55. Modificado de: San Martín H, Pastor V. Ibid., p.61

  56. Laín Entralgo P. La medicina actual. Seminarios y Ediciones, S.A. (ed.). Madrid, Esp., 1973:106-116

  57. Laín Entralgo P. Ibid., p. 120

  58. San Martín H, Pastor V. Ibid., p. 120

  59. Kuttner R. The American Health Care System. Employer-sponsored health coverage. N Engl J Med 1999;340:248-252.

  60. Modificado de: Biagi Filizola F. El ejercicio de la medicina en los tiempos de la globalización. Versión en computadora; 2000:12.

  61. 1. Bodenheimerj. The American Care System. Physicians and the changing medical marketplace. N Engl J Med 1999;340:584.

  62. 2. De Ville K. Act first, look up the law afterward? Medical malpractice and the ethics of defensive medicine. Theor Med Bioeth Dec. 1998;19(6):569-8.

  63. 3. Summerton N. Positive and negative factors in defensive medicine: a questionnaire study of general practitioners. Br Med J Jan 1995;7;310(6971):27-9.

  64. 4. Relationship between malpractice claims and caesarean delivery. JAMA 1993;263(3):366-373.

  65. 5. Lifshitz A. La conducta profesional del médico y los derechos humanos en el ejercicio actual de la medicina. No publicado.

  66. 6. López-Cervantes M. La mala administración de los servicios de salud. El ejercicio actual de la medicina. Siglo XXI editores; 1a. edición México: 2000. p. 157-62. isbn 968-36-8140-9.

  67. 7. Word CJ. Analysis of 500 obstetric and gynecologic malpractice claims: causes and prevention. An J Obstet Gynecol 1992;67(1);295-6.

  68. 8. Baldwin LM, et al. Defensive medicine and obstetrics. JAMA 1995;274(20):160-610.

  69. 9. Korcok M. CMPA does not atone impursuing huge reserves, CAMAJ survey of firms reveals. Can Med Assoc J 1996:154(12):1891-94.

  70. Brau RH. Impericia medica en Puerto Rico: 1990-96. PR Pealth Sci J Mar; 1998;17(1):55-67.

  71. Comisión Nacional de Arbitraje Médico. Informe de Actividades 1996-99. México.




2020     |     www.medigraphic.com